A prospective randomized controlled trial of sclerotherapy vs ligation in the prophylactic treatment of high-risk esophageal varices
- PMID: 10347295
- DOI: 10.1007/s004649901045
A prospective randomized controlled trial of sclerotherapy vs ligation in the prophylactic treatment of high-risk esophageal varices
Abstract
Background: Endoscopic ligation (EVL) and endoscopic sclerotherapy (EIS) are both effective in the treatment of bleeding esophageal varices, but the efficacy of the two techniques in the prophylaxis of first variceal bleeding has not been investigated. The aim of this study was to investigate the frequency of first variceal bleeding, the recurrence of varices, and survival after treatment with the two techniques, as compared to a nontreated control group.
Methods: A total of 157 patients with liver cirrhosis and advanced esophageal varices with no previous history of upper gastrointestinal bleeding were randomly assigned to either an EIS group (n = 55), an EVL group (n = 52), or a nontreated control group (n = 50). After the eradication of esophageal varices in the EIS and in EVL groups and in all control patients, the endoscopic examination was performed at 3-month intervals.
Results: There were no significant differences between EIS and EVL in the eradication rate of esophageal varices (85% in the EIS group versus 81% in the EVL group). The mean number of sessions required to obtain eradication was lower in the EVL group than in the EIS group (4.8 +/- 1.8 versus 6.2 +/- 2.0; p = 0.0003), but the recurrence of esophageal varices was higher in the EVL group (31% versus 11%; p = 0.01). Total mortality was significantly lower in the EIS patients than in the controls (20% versus 38%; p = 0.04). It was also lower, but not significantly, in the EVL patients than in the controls (23% versus 38%; p = 0.10). A significant decrease in variceal bleeding was observed both in sclerotherapy cases (20%) and controls (54%; p = 0.0005) and in ligation cases and controls (29%; p = 0.01). No significant difference in bleeding episodes was observed between the sclerotherapy and ligation cases (p = 0.29). No serious complications were observed either in the EIS or EVL groups.
Conclusions: EIS and EVL are similarly effective in the prevention of first variceal bleeding. The choice between EIS and EVL depends on the skill of the endoscopic unit. For highly experienced surgeons facing no complications, sclerotherapy seems to be preferable; for all others, it is technically easier to perform ligation.
Similar articles
-
A Prospective Study of Endoscopic Injection Sclerotherapy and Endoscopic Variceal Ligation in the Treatment of Esophageal Varices.J Laparoendosc Adv Surg Tech A. 2017 Apr;27(4):333-341. doi: 10.1089/lap.2016.0436. Epub 2016 Oct 24. J Laparoendosc Adv Surg Tech A. 2017. PMID: 28221819 Clinical Trial.
-
Endoscopic variceal ligation compared with endoscopic injection sclerotherapy for treatment of esophageal variceal hemorrhage: a meta-analysis.World J Gastroenterol. 2015 Feb 28;21(8):2534-41. doi: 10.3748/wjg.v21.i8.2534. World J Gastroenterol. 2015. PMID: 25741164 Free PMC article. Review.
-
Repeated injection sclerotherapy is preferable to combined therapy with variceal ligation to avoid recurrence of esophageal varices:--a prospective randomized trial.Hepatogastroenterology. 1997 Mar-Apr;44(14):467-71. Hepatogastroenterology. 1997. PMID: 9164520 Clinical Trial.
-
Novel balloon compression-assisted endoscopic injection sclerotherapy and endoscopic variceal ligation in the treatment of esophageal varices: a prospective randomized study.Surg Endosc. 2022 Oct;36(10):7839-7847. doi: 10.1007/s00464-022-09412-6. Epub 2022 Jul 25. Surg Endosc. 2022. PMID: 35879573 Free PMC article. Clinical Trial.
-
Endoscopic band ligation of oesophageal varices.Br J Surg. 1999 Apr;86(4):437-46. doi: 10.1046/j.1365-2168.1999.01109.x. Br J Surg. 1999. PMID: 10215811 Review.
Cited by
-
Foam sclerotherapy using polidocanol for balloon-occluded retrograde transvenous obliteration (BRTO).Eur Radiol. 2011 Jan;21(1):122-9. doi: 10.1007/s00330-010-1895-3. Epub 2010 Aug 26. Eur Radiol. 2011. PMID: 20737152 Clinical Trial.
-
Role of combined propofol and sufentanil anesthesia in endoscopic injection sclerotherapy for esophageal varices.World J Gastroenterol. 2017 Nov 28;23(44):7875-7880. doi: 10.3748/wjg.v23.i44.7875. World J Gastroenterol. 2017. PMID: 29209128 Free PMC article. Clinical Trial.
-
A novel therapeutic strategy for esophageal varices using endoscopic treatment combined with splenic artery embolization according to the Child-Pugh classification.PLoS One. 2019 Sep 26;14(9):e0223153. doi: 10.1371/journal.pone.0223153. eCollection 2019. PLoS One. 2019. PMID: 31557230 Free PMC article.
-
Two randomized controlled studies comparing the nutritional benefits of branched-chain amino acid (BCAA) granules and a BCAA-enriched nutrient mixture for patients with esophageal varices after endoscopic treatment.J Gastroenterol. 2015 Jan;50(1):109-18. doi: 10.1007/s00535-014-0950-2. Epub 2014 Mar 17. J Gastroenterol. 2015. PMID: 24633624 Free PMC article. Clinical Trial.
-
Study of hemodynamic changes in portal systemic shunts and their relation to variceal relapse after endoscopic variceal ligation combined with ethanol sclerotherapy.J Gastroenterol. 2006 Feb;41(2):119-26. doi: 10.1007/s00535-005-1730-9. J Gastroenterol. 2006. PMID: 16568370
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical